Claret Medical

Claret Medical

Claret Medical develops cerebral vascular protection systems for Transcatheter Aortic Valve Implantation (TAVI) and other procedures. Learn more

Launch date
Market cap
-
Enterprise valuation
€245m (Public information from Jul 2018)
Santa Rosa California (HQ)
  • Edit
DateInvestorsAmountRound
N/A

$1.3m

Early VC
N/A

$164k

Debt
N/A

$250k

Debt
N/A

$3.4m

Series A
N/A

$3.6m

Debt

$18.0m

Series B

N/A

Series C

$14.5m

Series C

$270m

Valuation: $270m

Acquisition
Total Funding€33.8m

Recent News about Claret Medical

Edit
More about Claret Medicalinfo icon
Edit

Claret Medical specializes in developing advanced cerebral protection systems designed to safeguard patients during cardiovascular procedures. Operating in the medical device industry, Claret Medical serves healthcare professionals and institutions focused on interventional cardiology. The company's core product, the Sentinel Cerebral Protection System, is engineered to capture and remove debris dislodged during heart valve procedures, thereby reducing the risk of stroke. Claret Medical generates revenue through the sale of its proprietary medical devices and ongoing support services. The company targets hospitals, clinics, and specialized cardiovascular centers, aiming to improve patient outcomes and procedural safety.

Keywords: cerebral protection, cardiovascular procedures, medical devices, interventional cardiology, stroke prevention, healthcare professionals, Sentinel system, debris capture, patient safety, procedural innovation.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.